EPIC-KOPhotobiomodulation and Diclofenac for Knee Osteoarthritis
Photobiomodulation therapy (PBM) device
+ Diclofenac Sodium 1 % Topical Cream
+ Placebo topical cream
Treatment Study
Summary
Study start date: January 1, 2026
Actual date on which the first participant was enrolled.This study is focused on finding better ways to reduce inflammation and pain in people who have knee osteoarthritis, a common joint condition that can make movement difficult. Researchers are testing two treatments: a light therapy called photobiomodulation (PBM), which uses specific wavelengths of light to help with healing, and a gel containing diclofenac, a medicine often used to treat pain and inflammation. The main goal is to see if using both treatments together is more effective than using just the light therapy alone, which could lead to improved joint function and less pain for those suffering from this condition. Participants in the study will receive either the combined treatment of PBM and diclofenac gel or just the PBM therapy. The PBM therapy involves using a device that emits light directly onto the knee, while the diclofenac is applied as a gel on the skin. Scientists will monitor changes in pain levels, swelling, and how well the knee functions over time. By measuring these outcomes, the study aims to understand the benefits, if any, of combining these treatments, which could provide a new, more effective approach for managing knee osteoarthritis symptoms.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 50 to 99 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.4 intervention groups are designated in this study
25% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
ExperimentalGroup IV
PlaceboStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location